306 related articles for article (PubMed ID: 18031373)
1. Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma.
Li YY; Sha WH; Zhou YJ; Nie YQ
J Gastroenterol Hepatol; 2007 Dec; 22(12):2148-54. PubMed ID: 18031373
[TBL] [Abstract][Full Text] [Related]
2. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
[TBL] [Abstract][Full Text] [Related]
3. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
Li CX; Wu PH; Fan WJ; Huang JH; Zhang FJ; Zhang L; Gu YK; Zhao M; Gao F; Jiao DC
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(11):754-7. PubMed ID: 19595104
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma.
Li C; Zhang W; Zhang R; Zhang L; Wu P; Zhang F
Eur J Cancer; 2010 Sep; 46(13):2513-21. PubMed ID: 20663659
[TBL] [Abstract][Full Text] [Related]
5. High intensity focused ultrasound (HIFU) therapy for local treatment of hepatocellular carcinoma: role of partial rib resection.
Zhu H; Zhou K; Zhang L; Jin C; Peng S; Yang W; Li K; Su H; Chen W; Bai J; Wu F; Wang Z
Eur J Radiol; 2009 Oct; 72(1):160-6. PubMed ID: 18707834
[TBL] [Abstract][Full Text] [Related]
6. High-intensity focused ultrasound combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: long-term follow-up and clinical analysis.
Jin C; Zhu H; Wang Z; Wu F; Chen W; Li K; Su H; Zhou K; Gong W
Eur J Radiol; 2011 Dec; 80(3):662-9. PubMed ID: 20864286
[TBL] [Abstract][Full Text] [Related]
7. Follow-up of high-intensity focused ultrasound treatment for patients with hepatocellular carcinoma.
Xu G; Luo G; He L; Li J; Shan H; Zhang R; Li Y; Gao X; Lin S; Wang G
Ultrasound Med Biol; 2011 Dec; 37(12):1993-9. PubMed ID: 22036638
[TBL] [Abstract][Full Text] [Related]
8. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization.
Wu F; Wang ZB; Chen WZ; Zou JZ; Bai J; Zhu H; Li KQ; Jin CB; Xie FL; Su HB
Radiology; 2005 May; 235(2):659-67. PubMed ID: 15858105
[TBL] [Abstract][Full Text] [Related]
9. [The study of clinical application of high intensity focused ultrasound in non-invasive therapy for liver cancer].
Yi J; Li N; Jiang LS; Xiong XZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):426-8. PubMed ID: 15931887
[TBL] [Abstract][Full Text] [Related]
10. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
11. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
[TBL] [Abstract][Full Text] [Related]
12. Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas.
Cheung TT; Poon RT; Jenkins CR; Chu FS; Chok KS; Chan AC; Tsang SH; Dai WC; Yau TC; Chan SC; Fan ST; Lo CM
Liver Int; 2014 Jul; 34(6):e136-43. PubMed ID: 24451026
[TBL] [Abstract][Full Text] [Related]
13. [Clinical observation on high intensity focused ultrasound combined with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma].
Wu Y; Li J; Zhang SJ; Zhao YF; Zhao LS; Ma XX; Feng LS; Fan ZJ
Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):691-4. PubMed ID: 23157899
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of short-term response of high intensity focused ultrasound ablation for primary hepatic carcinoma: utility of contrast-enhanced MRI and diffusion-weighted imaging.
Zhang Y; Zhao J; Guo D; Zhong W; Ran L
Eur J Radiol; 2011 Sep; 79(3):347-52. PubMed ID: 20638211
[TBL] [Abstract][Full Text] [Related]
15. Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response.
Guglielmi A; Ruzzenente A; Pachera S; Valdegamberi A; Sandri M; D'Onofrio M; Iacono C
Am J Gastroenterol; 2008 Mar; 103(3):597-604. PubMed ID: 17970836
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cells in patients with solid malignancy treated by high-intensity focused ultrasound.
Wu F; Wang ZB; Jin CB; Zhang JP; Chen WZ; Bai J; Zou JZ; Zhu H
Ultrasound Med Biol; 2004 Apr; 30(4):511-7. PubMed ID: 15121253
[TBL] [Abstract][Full Text] [Related]
17. Changes in circulating immunosuppressive cytokine levels of cancer patients after high intensity focused ultrasound treatment.
Zhou Q; Zhu XQ; Zhang J; Xu ZL; Lu P; Wu F
Ultrasound Med Biol; 2008 Jan; 34(1):81-7. PubMed ID: 17854983
[TBL] [Abstract][Full Text] [Related]
18. Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study.
Kudo M; Sakaguchi Y; Chung H; Hatanaka K; Hagiwara S; Ishikawa E; Takahashi S; Kitai S; Inoue T; Minami Y; Ueshima K
Oncology; 2007; 72 Suppl 1():132-8. PubMed ID: 18087194
[TBL] [Abstract][Full Text] [Related]
19. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
Yu Y; Lang Q; Chen Z; Li B; Yu C; Zhu D; Zhai X; Ling C
Cancer; 2009 Nov; 115(22):5132-8. PubMed ID: 19672999
[TBL] [Abstract][Full Text] [Related]
20. Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma.
Shao YY; Lin ZZ; Hsu C; Shen YC; Hsu CH; Cheng AL
Cancer; 2010 Oct; 116(19):4590-6. PubMed ID: 20572033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
